Skip to main content
Equibles
NPCE logo

NPCE · NeuroPace Inc · Metrics

Track NPCE — free

Use NPCE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NPCE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.91 -0.23 (-1.75%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$443.13M
Shares
34.32M
Volume · Oct 23 69.07K Avg daily vol (3M) 157.8K

NPCE metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.91
Market cap
$443.13M

Price action

20 metrics
Price change (1W)
+5.5%
Price change (30D)
-8.2%
Price change (3M)
-12.8%
Price change (6M)
-23.2%
Price change (YTD)
-16.4%
Price change (1Y)
+22.4%
Trailing year
Price change (5Y)
-17.2%
52-week high
$19.29
52-week low
$9.40
Change from 52-week high
-33.1%
Change from 52-week low
+37.3%
Annualized volatility
62.7%
Annualized volatility (3M)
49.6%
Beta
1.4
RSI (14D)
45.9
Price vs SMA 50
-6.7%
Price vs SMA 200
-14.4%
Avg volume (3M)
157,795
Relative volume
0.4
Average dollar volume
$2.21M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
34.32M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.4×
reciprocal yield 22.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.3×
reciprocal yield 23.2%
P / book
37.3
reciprocal yield 2.7%
FCF yield
-2.6%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.3×
reciprocal yield 23.1%
EV / revenue historical average (5Y)
3.8×
reciprocal yield 26.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
78.4%
Operating margin
-13.3%
Trailing 12 months
Net margin
-18.6%
Gross profit (TTM)
$80.62M
Operating profit (TTM)
−$13.71M
Net income (TTM)
−$19.11M
Trailing 12 months
Diluted EPS (TTM)
$-0.57
FCF margin
-11.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.07
Gross profit per diluted share (TTM)
$2.40
Operating profit per diluted share (TTM)
$-0.41
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.57
Operating cash flow per diluted share (TTM)
$-0.33
Free cash flow per diluted share (TTM)
$-0.34
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.82
Stock compensation per diluted share (TTM)
$0.29
Book value per share
$0.57

Growth

11 metrics
Revenue growth YoY
+17.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$102.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.8%
Year over year · more shares
Revenue CAGR (3Y)
+30.0%
Revenue CAGR (5Y)
+19.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-160.9%
Return on assets
-19.7%
Debt / equity
5.0
Current ratio
4.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$11.61M
Quick ratio
3.9
Interest coverage
-2.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$7.32M
Latest balance sheet
Cash & equivalents
$12.54M
Total assets
$96.99M
Total debt
$59.01M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$11.24M
Capital expenditures (TTM)
$369,000
R&D (TTM)
$27.69M
SG&A (TTM)
$57.05M
Stock compensation (TTM)
$9.82M
R&D / revenue
26.9%
Stock compensation / revenue
9.5%

Ownership (13F)

9 metrics
13F filers
112
13F filer change QoQ
-1
Institutional ownership
77.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
42.9%
Private-fund adviser ownership
33.5%
Active holders' share change QoQ
-2.2%
Holder tenure
11.1
Price vs estimated holder cost
+22.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.6%

Short interest

3 metrics
Short interest
2.6%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1528287 CUSIP 641288105 13F (30d) 7 filings 7 filers Visit website Investor relations